Mise en place d’une démarche de certification ISO 9001 d’une unité de radiopharmacie au sein du CHU de Toulouse von Chmielowski, C., Beaurain, M., Badier, L., Alonso, M., Salabert, A., Quelven, I.

Volltext

Volémie isotopique : description d’une population de 1058 patients ayant réalisés cet examen von Salabert, A.S., Gaisne, P., Chmielowski, C., Raimundo, N., Alonso, M., Payoux, P.

Volltext

Changement de pratique pour le radiomarquage des leucocytes : étude comparative de 3 méthodes de sédimentation von Badier, L., Beaurain, M., Alonso, M., Salabert, A.S., Chmielowski, C., Raimundo, N., Quelven, I.

Volltext

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma von Hugo, Willy, Zaretsky, Jesse M., Sun, Lu, Song, Chunying, Moreno, Blanca Homet, Hu-Lieskovan, Siwen, Berent-Maoz, Beata, Pang, Jia, Chmielowski, Bartosz, Cherry, Grace, Seja, Elizabeth, Lomeli, Shirley, Kong, Xiangju, Kelley, Mark C., Sosman, Jeffrey A., Johnson, Douglas B., Ribas, Antoni, Lo, Roger S.

Volltext

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma von Zaretsky, Jesse M, Garcia-Diaz, Angel, Shin, Daniel S, Escuin-Ordinas, Helena, Hugo, Willy, Hu-Lieskovan, Siwen, Torrejon, Davis Y, Abril-Rodriguez, Gabriel, Sandoval, Salemiz, Barthly, Lucas, Saco, Justin, Homet Moreno, Blanca, Mezzadra, Riccardo, Chmielowski, Bartosz, Ruchalski, Kathleen, Shintaku, I. Peter, Sanchez, Phillip J, Puig-Saus, Cristina, Cherry, Grace, Seja, Elizabeth, Kong, Xiangju, Pang, Jia, Berent-Maoz, Beata, Comin-Anduix, Begoña, Graeber, Thomas G, Tumeh, Paul C, Schumacher, Ton N.M, Lo, Roger S, Ribas, Antoni

Volltext

LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer von Tavazoie, Masoud F., Pollack, Ilana, Tanqueco, Raissa, Ostendorf, Benjamin N., Reis, Bernardo S., Gonsalves, Foster C., Kurth, Isabel, Andreu-Agullo, Celia, Derbyshire, Mark L., Posada, Jessica, Takeda, Shugaku, Tafreshian, Kimia N., Rowinsky, Eric, Szarek, Michael, Waltzman, Roger J., Mcmillan, Elizabeth A., Zhao, Connie, Mita, Monica, Mita, Alain, Chmielowski, Bartosz, Postow, Michael A., Ribas, Antoni, Mucida, Daniel, Tavazoie, Sohail F.

Volltext

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma von Hamid, Omid, Robert, Caroline, Daud, Adil, Hodi, F. Stephen, Hwu, Wen-Jen, Kefford, Richard, Wolchok, Jedd D, Hersey, Peter, Joseph, Richard W, Weber, Jeffrey S, Dronca, Roxana, Gangadhar, Tara C, Patnaik, Amita, Zarour, Hassane, Joshua, Anthony M, Gergich, Kevin, Elassaiss-Schaap, Jeroen, Algazi, Alain, Mateus, Christine, Boasberg, Peter, Tumeh, Paul C, Chmielowski, Bartosz, Ebbinghaus, Scot W, Li, Xiaoyun Nicole, Kang, S. Peter, Ribas, Antoni

Volltext

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma von Hugo, Willy, Zaretsky, Jesse M., Sun, Lu, Song, Chunying, Moreno, Blanca Homet, Hu-Lieskovan, Siwen, Berent-Maoz, Beata, Pang, Jia, Chmielowski, Bartosz, Cherry, Grace, Seja, Elizabeth, Lomeli, Shirley, Kong, Xiangju, Kelley, Mark C., Sosman, Jeffrey A., Johnson, Douglas B., Ribas, Antoni, Lo, Roger S.

Volltext

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial von Weber, Jeffrey S, Dr, D'Angelo, Sandra P, MD, Minor, David, MD, Hodi, F Stephen, MD, Gutzmer, Ralf, MD, Neyns, Bart, MD, Hoeller, Christoph, MD, Khushalani, Nikhil I, MD, Miller, Wilson H, MD, Lao, Christopher D, MD, Linette, Gerald P, MD, Thomas, Luc, MD, Lorigan, Paul, FRCP, Grossmann, Kenneth F, MD, Hassel, Jessica C, MD, Maio, Michele, MD, Sznol, Mario, MD, Ascierto, Paolo A, MD, Mohr, Peter, MD, Chmielowski, Bartosz, MD, Bryce, Alan, MD, Svane, Inge M, MD, Grob, Jean-Jacques, MD, Krackhardt, Angela M, MD, Horak, Christine, PhD, Lambert, Alexandre, PhD, Yang, Arvin S, MD, Larkin, James, FRCP

Volltext

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations von Shin, Daniel Sanghoon, Zaretsky, Jesse M, Escuin-Ordinas, Helena, Garcia-Diaz, Angel, Hu-Lieskovan, Siwen, Kalbasi, Anusha, Grasso, Catherine S, Hugo, Willy, Sandoval, Salemiz, Torrejon, Davis Y, Palaskas, Nicolaos, Rodriguez, Gabriel Abril, Parisi, Giulia, Azhdam, Ariel, Chmielowski, Bartosz, Cherry, Grace, Seja, Elizabeth, Berent-Maoz, Beata, Shintaku, I Peter, Le, Dung T, Pardoll, Drew M, Diaz, Jr, Luis A, Tumeh, Paul C, Graeber, Thomas G, Lo, Roger S, Comin-Anduix, Begoña, Ribas, Antoni

Volltext

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial von Robert, Caroline, Prof, Ribas, Antoni, Prof, Wolchok, Jedd D, Prof, Hodi, F Stephen, MD, Hamid, Omid, MD, Kefford, Richard, Prof, Weber, Jeffrey S, Prof, Joshua, Anthony M, PhD, Hwu, Wen-Jen, Prof, Gangadhar, Tara C, MD, Patnaik, Amita, MD, Dronca, Roxana, MD, Zarour, Hassane, Prof, Joseph, Richard W, MD, Boasberg, Peter, MD, Chmielowski, Bartosz, MD, Mateus, Christine, MD, Postow, Michael A, MD, Gergich, Kevin, MA, Elassaiss-Schaap, Jeroen, PhD, Li, Xiaoyun Nicole, PhD, Iannone, Robert, MD, Ebbinghaus, Scot W, MD, Kang, S Peter, MD, Daud, Adil, Prof

Volltext

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy von Shi, Hubing, Hugo, Willy, Kong, Xiangju, Hong, Aayoung, Koya, Richard C, Moriceau, Gatien, Chodon, Thinle, Guo, Rongqing, Johnson, Douglas B, Dahlman, Kimberly B, Kelley, Mark C, Kefford, Richard F, Chmielowski, Bartosz, Glaspy, John A, Sosman, Jeffrey A, van Baren, Nicolas, Long, Georgina V, Ribas, Antoni, Lo, Roger S

Volltext

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib von Sosman, Jeffrey A, Kim, Kevin B, Schuchter, Lynn, Gonzalez, Rene, Pavlick, Anna C, Weber, Jeffrey S, McArthur, Grant A, Hutson, Thomas E, Moschos, Stergios J, Flaherty, Keith T, Hersey, Peter, Kefford, Richard, Lawrence, H. Jeffrey, Lawrence, Donald, Puzanov, Igor, Lewis, Karl D, Amaravadi, Ravi K, Chmielowski, Bartosz, Shyr, Yu, Ye, Fei, Li, Jiang, Nolop, Keith B, Lee, Richard J, Joe, Andrew K, Ribas, Antoni

Volltext

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase II... von Larkin, James, Minor, David, D'Angelo, Sandra, Neyns, Bart, Smylie, Michael, Miller, Jr, Wilson H, Gutzmer, Ralf, Linette, Gerald, Chmielowski, Bartosz, Lao, Christopher D, Lorigan, Paul, Grossmann, Kenneth, Hassel, Jessica C, Sznol, Mario, Daud, Adil, Sosman, Jeffrey, Khushalani, Nikhil, Schadendorf, Dirk, Hoeller, Christoph, Walker, Dana, Kong, George, Horak, Christine, Weber, Jeffrey

Volltext

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma von Nathan, Paul, Hassel, Jessica C, Rutkowski, Piotr, Baurain, Jean-Francois, Butler, Marcus O, Schlaak, Max, Sullivan, Ryan J, Ochsenreither, Sebastian, Dummer, Reinhard, Kirkwood, John M, Joshua, Anthony M, Sacco, Joseph J, Shoushtari, Alexander N, Orloff, Marlana, Piulats, Josep M, Milhem, Mohammed, Salama, April K.S, Curti, Brendan, Demidov, Lev, Gastaud, Lauris, Mauch, Cornelia, Yushak, Melinda, Carvajal, Richard D, Hamid, Omid, Abdullah, Shaad E, Holland, Chris, Goodall, Howard, Piperno-Neumann, Sophie

Volltext

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma von Patel, Sapna P., Othus, Megan, Chen, Yuanbin, Wright, G. Paul, Yost, Kathleen J., Hyngstrom, John R., Hu-Lieskovan, Siwen, Lao, Christopher D., Fecher, Leslie A., Truong, Thach-Giao, Eisenstein, Jennifer L., Chandra, Sunandana, Sosman, Jeffrey A., Kendra, Kari L., Wu, Richard C., Devoe, Craig E., Deutsch, Gary B., Hegde, Aparna, Khalil, Maya, Mangla, Ankit, Reese, Amy M., Ross, Merrick I., Poklepovic, Andrew S., Phan, Giao Q., Onitilo, Adedayo A., Yasar, Demet G., Powers, Benjamin C., Doolittle, Gary C., In, Gino K., Kokot, Niels, Gibney, Geoffrey T., Atkins, Michael B., Shaheen, Montaser, Warneke, James A., Ikeguchi, Alexandra, Najera, Jose E., Chmielowski, Bartosz, Crompton, Joseph G., Floyd, Justin D., Hsueh, Eddy, Margolin, Kim A., Chow, Warren A., Grossmann, Kenneth F., Dietrich, Eliana, Prieto, Victor G., Lowe, Michael C., Buchbinder, Elizabeth I., Kirkwood, John M., Korde, Larissa, Moon, James, Sharon, Elad, Sondak, Vernon K., Ribas, Antoni

Volltext

PD-1 blockade induces responses by inhibiting adaptive immune resistance von Tumeh, Paul C., Harview, Christina L., Yearley, Jennifer H., Shintaku, I. Peter, Taylor, Emma J. M., Robert, Lidia, Chmielowski, Bartosz, Spasic, Marko, Henry, Gina, Ciobanu, Voicu, West, Alisha N., Carmona, Manuel, Kivork, Christine, Seja, Elizabeth, Cherry, Grace, Gutierrez, Antonio J., Grogan, Tristan R., Mateus, Christine, Tomasic, Gorana, Glaspy, John A., Emerson, Ryan O., Robins, Harlan, Pierce, Robert H., Elashoff, David A., Robert, Caroline, Ribas, Antoni

Volltext

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma von Ribas, Antoni, Hamid, Omid, Daud, Adil, Hodi, F. Stephen, Wolchok, Jedd D, Kefford, Richard, Joshua, Anthony M, Patnaik, Amita, Hwu, Wen-Jen, Weber, Jeffrey S, Gangadhar, Tara C, Hersey, Peter, Dronca, Roxana, Joseph, Richard W, Zarour, Hassane, Chmielowski, Bartosz, Lawrence, Donald P, Algazi, Alain, Rizvi, Naiyer A, Hoffner, Brianna, Mateus, Christine, Gergich, Kevin, Lindia, Jill A, Giannotti, Maxine, Li, Xiaoyun Nicole, Ebbinghaus, Scot, Kang, S. Peter, Robert, Caroline

Volltext

Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas von Lin, Anthony Y., MD, Kotova, Svetlana, MD, Yanagawa, Jane, MD, Elbuluk, Osama, BS, Wang, Gerald, BS, Kar, Nivedita, BS, Elashoff, David, PhD, Grogan, Tristan, MS, Cameron, Robert B., MD, Singh, Arun, MD, Chmielowski, Bartosz, MD, Federman, Noah, MD, Nelson, Scott D., MD, Lee, Percy, MD, Eilber, Fritz C., MD, Lee, Jay M., MD

Volltext

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans von RONG RONG HUANG, JALIL, Jason, GLASPY, John A, COCHRAN, Alistair J, RIBAS, Antoni, ECONOMOU, James S, CHMIELOWSKI, Bartosz, KOYA, Richard C, MOK, Stephen, SAZEGAR, Hooman, SEJA, Elizabeth, VILLANUEVA, Arturo, GOMEZ-NAVARRO, Jesus

Volltext